14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PACB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Pacific Biosciences of California stock price on Monday moving between $1.88 and $2.18
(Updated on May 06, 2024)

Sell candidate since May 06, 2024 PDF

The Pacific Biosciences of California stock price gained 8.74% on the last trading day (Monday, 6th May 2024), rising from $1.83 to $1.99. It has now gained 8 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 16.27% from a day low at $1.88 to a day high of $2.18. The price has risen in 8 of the last 10 days and is up by 27.56% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 million more shares were traded than the day before. In total, 19 million shares were bought and sold for approximately $37.12 million.

Given the current short-term trend, the stock is expected to fall -72.36% during the next 3 months and, with a 90% probability hold a price between $0.187 and $0.550 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PACB Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has risen 46.32%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pacific Biosciences of California stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.68. On a fall, the stock will find some support from the short-term average at $1.71. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Pacific Biosciences of California stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.83 and $1.69. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Pacific Biosciences of California finds support just below today's level at $1.83. If this is broken, then the next support from accumulated volume will be at $1.69 and $1.55.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.305 between high and low, or 16.27%. For the last week, the stock has had daily average volatility of 14.03%.

The Pacific Biosciences of California stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs. Since the Pacific Biosciences of California has been rising for 8 days in a row, the risk over the next couple of days has increased.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PACB) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Pacific Biosciences of California to open at $2.02, and during the day (based on 14 day Average True Range), to move between $1.71 and $2.27, which gives a possible trading interval of +/-$0.284 (+/-14.27%) up or down from last closing price. If Pacific Biosciences of California takes out the full calculated possible swing range there will be an estimated 28.54% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $1.83, some $0.160 (8.04%) from the current price of $1.99, our system finds the risk reward attractive.

Earnings coming up

Pacific Biosciences of California will release earnings AMC on Tuesday, May 07, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.260. We will update the financials statements for Pacific Biosciences of California, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.63% in the first trading day after earnings release.

Is Pacific Biosciences of California stock A Buy?

Pacific Biosciences of California holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.250 Sell Candidate Downgraded

Predicted Opening Price for Pacific Biosciences of California of Tuesday, May 7, 2024

Fair opening price May 7, 2024 Current price
$2.02 ( 1.26%) $1.99

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PACB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.32 16.58 %
R2 2.20 10.73 %
R1 2.13 7.11 %
Current price: 1.99
Support S1 1.90 -4.60 %
S2 1.83 -8.22 %
S3 1.71 -14.07 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 1.99
Support S1 1.83 -8.04%
S2 1.69 -15.08%
S3 1.55 -22.11%

FAQ

What is the symbol for Pacific Biosciences of California Stock and on which exchange is it traded?
The symbol for Pacific Biosciences of California is PACB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pacific Biosciences of California Stock?
Pacific Biosciences of California holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Pacific Biosciences of California Stock?
Pacific Biosciences of California Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pacific Biosciences of California Stock.

What's the current price of Pacific Biosciences of California Stock?
As of the end of day on the May 06, 2024, the price of an Pacific Biosciences of California (PACB) share was $1.99.

What is the 52-week high and low for Pacific Biosciences of California Stock?
The 52-week high for Pacific Biosciences of California Stock is $14.55 and the 52-week low is $1.25.

What is the market capitalization of Pacific Biosciences of California Stock?
As of the May 06, 2024, the market capitalization of Pacific Biosciences of California is 533.224M.

When is the next earnings date for Pacific Biosciences of California?
The upcoming earnings date for Pacific Biosciences of California is May 07, 2024.
Click to get the best stock tips daily for free!

About Pacific Biosciences of California

Pacific Biosciences of California Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded... PACB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT